Clinical Pharmacokinetics of Allopurinol
- 1 January 1986
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 11 (5) , 343-353
- https://doi.org/10.2165/00003088-198611050-00001
Abstract
Allopurinol is a widely used drug in the management of hyperuricaemia. It is rapidly and extensively absorbed following oral administration. The major and active metabolite, oxypurinol, is detected in the circulation within 15 minutes of allopurinol administration. Oxypurinol concentrations are higher than those of the parent drug and accumulation occurs during long term administration. Up to 80% of allopurinol is recovered in the urine within 24 hours, mainly in the form of oxypurinol. Allopurinol is negligibly absorbed after rectal administration. In animals, allopurinol is found in highest concentrations in vascular tissue, blood, liver, intestine and heart. It is negligibly bound to plasma proteins. Oxypurinol is eliminated by the kidney and has a much longer elimination half-life than allopurinol. Oxypurinol accumulates in patients with renal dysfunction; hence allopurinol dosages should be adjusted in such patients. Allopurinol inhibits the metabolism of 6-mercaptopurine and azathioprine, which require dosage modifications. The interaction of allopurinol with oral anticoagulants and phenytoin has not been clearly established in clinical practice.Keywords
This publication has 33 references indexed in Scilit:
- Allopurinol Absorption from Different Sites of the Rat Gastrointestinal TractJournal of Pharmaceutical Sciences, 1986
- The Effect of Dietary Protein on the Clearance of Allopurinol and OxypurinolNew England Journal of Medicine, 1985
- Identification of Hypoxanthine Transport and Xanthine Oxidase Activity in Brain CapillariesJournal of Neurochemistry, 1985
- Does benzbromarone in therapeutic doses raise renal excretion of oxipurinol?Journal of Molecular Medicine, 1984
- Localization of xanthine oxidase in mammary-gland epithelium and capillary endotheliumCell, 1981
- Analysis of allopurinol and oxypurinol in plasma and its application to metabolic studiesBiopharmaceutics & Drug Disposition, 1980
- Severe allopurinol hypersensitivity. Association with thiazides and prior renal compromiseArchives of internal medicine (1960), 1974
- POTENTIATION OF AN EFFECT OF ALLOPURINOL ON PYRIMIDINE METABOLISM BY CHLOROTHIAZIDE IN MANClinical and Experimental Pharmacology and Physiology, 1974
- Formation of nucleotides of [6-14C]allopurinol and [6-14C]oxipurinol in rat tissues and effects on uridine nucleotide poolsBiochemical Pharmacology, 1973
- Metabolic studies of allopurinol, an inhibitor of xanthine oxidaseBiochemical Pharmacology, 1966